
LINK . SPRINGER . COM {
}
Title:
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma | Molecular Cancer
Description:
Background Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. Methods To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. Results We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Conclusions Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
The income method remains a mystery to us.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.
Keywords {🔍}
cells, relapse, fig, cell, expression, pubmed, tigit, tcell, article, mcl, patients, tumor, google, scholar, car, central, supplementary, cancer, myeloid, patient, cytotoxic, ctls, cas, data, remission, lymphoma, therapy, receptor, immune, resistance, samples, increased, soluble, silr, hla, checkpoint, levels, wang, showing, panel, molecules, expressed, study, analysis, mechanisms, collected, significantly, elevated, genes, singlecell,
Topics {✒️}
single-cell t-cell receptor v-set immunoregulatory receptor scrna-seq/tcr library preparation large b-cell lymphoma phorbol 12-myristate 13-acetate/ionomycin inhibiting t-cell expansion article download pdf refractory mantle-cell lymphoma post-relapse hla-ii expression serine/threonine protein kinase car t-cell failure myeloid-derived suppressor cells car t-treated diseases perform single-cell separation sequential single-cell transcriptional mdsc-mediated immune suppression car-t-cell therapy car t-cell therapy car t-cell activity t-cell clone sizes trans-differentiation methylation profile cell-mediated cyeloid activation car t-cell therapies endogenous t-cell suppression car t-cell therapeutics car t-cell resistance building single-cell trajectory car t-cell exhaustion cytotoxic/exhaustion/naïve scoring algorithm regulating t-cell function cd8+ t-cell subpopulations andrew futreal & linghua wang car t-cell relapse exhausted t-cell clones myeloid-derived suppressive cells enhance cancer immunotherapy-focus serum-derived exosomes isolated therapy-induced pim1 activation immune cell populations checkpoint molecules spd-l1 tcr-independent stimulator targeting pim1-mediated metabolism cell infusion products anti-tumor cytotoxic killing human leukocyte antigens t-cell suppression mantle cell lymphoma single cells color-coded showed transcriptomic reprogramming 2d-density plots showing
Schema {🗺️}
WebPage:
mainEntity:
headline:TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
description:Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
datePublished:2022-09-26T00:00:00Z
dateModified:2022-09-26T00:00:00Z
pageStart:1
pageEnd:16
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12943-022-01655-0
keywords:
Mantle cell lymphoma
CAR T-cell therapy
Relapse
T cell suppression
Myeloid-derived suppressor cells
Immune checkpoint
TIGIT
Cytokines
Chemokines
Soluble receptors
Cancer Research
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig6_HTML.png
isPartOf:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Vivian Changying Jiang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Dapeng Hao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Preetesh Jain
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yijing Li
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Qingsong Cai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yixin Yao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Lei Nie
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yang Liu
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Jingling Jin
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Wei Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Heng-Huan Lee
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yuxuan Che
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Enyu Dai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Guangchun Han
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Ruiping Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Kunal Rai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Andrew Futreal
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Christopher Flowers
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Linghua Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Michael Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
description:Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
datePublished:2022-09-26T00:00:00Z
dateModified:2022-09-26T00:00:00Z
pageStart:1
pageEnd:16
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12943-022-01655-0
keywords:
Mantle cell lymphoma
CAR T-cell therapy
Relapse
T cell suppression
Myeloid-derived suppressor cells
Immune checkpoint
TIGIT
Cytokines
Chemokines
Soluble receptors
Cancer Research
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig6_HTML.png
isPartOf:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Vivian Changying Jiang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Dapeng Hao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Preetesh Jain
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yijing Li
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Qingsong Cai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yixin Yao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Lei Nie
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yang Liu
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Jingling Jin
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Wei Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Heng-Huan Lee
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yuxuan Che
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Enyu Dai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Guangchun Han
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Ruiping Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Kunal Rai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Andrew Futreal
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Christopher Flowers
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Linghua Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Michael Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:21
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Vivian Changying Jiang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Dapeng Hao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Preetesh Jain
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yijing Li
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Qingsong Cai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yixin Yao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Lei Nie
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yang Liu
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Jingling Jin
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Wei Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Heng-Huan Lee
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yuxuan Che
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Enyu Dai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Guangchun Han
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Ruiping Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Kunal Rai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Andrew Futreal
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Christopher Flowers
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Linghua Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Michael Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
External Links {🔗}(231)
- What's the financial outcome of https://www.springernature.com/gp/authors?
- How much revenue does https://link.springernature.com/home/ generate?
- How much does https://order.springer.com/public/cart make?
- Get to know what's the income of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- https://molecular-cancer.biomedcentral.com/about's financial summary
- Get to know what's the income of https://submission.nature.com/new-submission/12943/3
- Financial intake of https://doi.org/10.1056%2FNEJMoa1914347
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32242358
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731441's revenue stream
- What's the income of http://scholar.google.com/scholar_lookup?&title=KTE-X19%20CAR%20T-cell%20therapy%20in%20relapsed%20or%20refractory%20mantle-cell%20lymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1914347&volume=382&pages=1331-1342&publication_year=2020&author=Wang%2CM&author=Munoz%2CJ&author=Goy%2CA&author=Locke%2CFL&author=Jacobson%2CCA&author=Hill%2CBT&author=Timmerman%2CJM&author=Holmes%2CH&author=Jaglowski%2CS&author=Flinn%2CIW?
- Discover the revenue of https://doi.org/10.1111%2Fbjh.17197
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33152104?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Outcomes%20and%20management%20of%20patients%20with%20mantle%20cell%20lymphoma%20after%20progression%20on%20brexucabtagene%20autoleucel%20therapy&journal=Br%20J%20Haematol&doi=10.1111%2Fbjh.17197&volume=192&pages=e38-e42&publication_year=2021&author=Jain%2CP&author=Nastoupil%2CL&author=Westin%2CJ&author=Lee%2CHJ&author=Navsaria%2CL&author=Steiner%2CRE&author=Ahmed%2CS&author=Moghrabi%2CO&author=Oriabure%2CO&author=Chen%2CW?
- What's the monthly income of https://doi.org/10.1056%2FNEJMoa1707447?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29226797 generate?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882485
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Axicabtagene%20ciloleucel%20CAR%20T-cell%20therapy%20in%20refractory%20large%20B-cell%20cymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1707447&volume=377&pages=2531-2544&publication_year=2017&author=Neelapu%2CSS&author=Locke%2CFL&author=Bartlett%2CNL&author=Lekakis%2CLJ&author=Miklos%2CDB&author=Jacobson%2CCA&author=Braunschweig%2CI&author=Oluwole%2COO&author=Siddiqi%2CT&author=Lin%2CY?
- How much does https://doi.org/10.1056%2FNEJMoa1804980 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30501490 gross monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Tisagenlecleucel%20in%20adult%20relapsed%20or%20refractory%20diffuse%20large%20B-cell%20lymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1804980&volume=380&pages=45-56&publication_year=2019&author=Schuster%2CSJ&author=Bishop%2CMR&author=Tam%2CCS&author=Waller%2CEK&author=Borchmann%2CP&author=McGuirk%2CJP&author=Jager%2CU&author=Jaglowski%2CS&author=Andreadis%2CC&author=Westin%2CJR earns monthly
- Check the income stats for https://doi.org/10.1182%2Fblood.2020007445
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33512407 pull in?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120145 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20interferon%20signaling%20and%20suppressive%20myeloid%20cells%20are%20associated%20with%20CAR%20T-cell%20failure%20in%20large%20B-cell%20lymphoma&journal=Blood&doi=10.1182%2Fblood.2020007445&volume=137&pages=2621-2633&publication_year=2021&author=Jain%2CMD&author=Zhao%2CH&author=Wang%2CX&author=Atkins%2CR&author=Menges%2CM&author=Reid%2CK&author=Spitler%2CK&author=Faramand%2CR&author=Bachmeier%2CC&author=Dean%2CEA bring in each month?
- How much does https://doi.org/10.1158%2F2159-8290.CD-19-0813 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32001516 pull in monthly?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416790?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Impaired%20death%20receptor%20signaling%20in%20leukemia%20causes%20antigen-independent%20resistance%20by%20inducing%20CAR%20T-cell%20dysfunction&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-19-0813&volume=10&pages=552-567&publication_year=2020&author=Singh%2CN&author=Lee%2CYG&author=Shestova%2CO&author=Ravikumar%2CP&author=Hayer%2CKE&author=Hong%2CSJ&author=Lu%2CXM&author=Pajarillo%2CR&author=Agarwal%2CS&author=Kuramitsu%2CS make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30837712 generate?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214555 gross monthly?
- http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20CAR%20T%20cell%20therapy&journal=Nat%20Rev%20Clin%20Oncol&volume=16&pages=372-385&publication_year=2019&author=Shah%2CNN&author=Fry%2CTJ's revenue stream
- What's the income of https://doi.org/10.1016%2Fj.coi.2021.02.010?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33752101 bring in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20response%20and%20resistance%20to%20CAR%20T%20cell%20therapies&journal=Curr%20Opin%20Immunol&doi=10.1016%2Fj.coi.2021.02.010&volume=69&pages=56-64&publication_year=2021&author=Berger%2CTR&author=Maus%2CMV make?
- Discover the revenue of https://doi.org/10.1158%2F2159-8290.CD-19-0945
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32193224 gross monthly?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939454?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Tuning%20the%20antigen%20density%20requirement%20for%20CAR%20T-cell%20activity&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-19-0945&volume=10&pages=702-723&publication_year=2020&author=Majzner%2CRG&author=Rietberg%2CSP&author=Sotillo%2CE&author=Dong%2CR&author=Vachharajani%2CVT&author=Labanieh%2CL&author=Myklebust%2CJH&author=Kadapakkam%2CM&author=Weber%2CEW&author=Tousley%2CAM?
- How much does https://doi.org/10.3389%2Ffimmu.2019.02664 bring in each month?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31798590 earning monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863137 produce monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20relapse%20after%20CD19%20CAR%20T-cell%20therapy%20for%20acute%20lymphoblastic%20leukemia%20and%20its%20prevention%20and%20treatment%20strategies&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2019.02664&volume=10&publication_year=2019&author=Xu%2CX&author=Sun%2CQ&author=Liang%2CX&author=Chen%2CZ&author=Zhang%2CX&author=Zhou%2CX&author=Li%2CM&author=Tu%2CH&author=Liu%2CY&author=Tu%2CS&author=Li%2CY
- Check the income stats for https://doi.org/10.1126%2Fsciimmunol.abd4344
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33771887
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=A%20cross-talk%20between%20CAR%20T%20cell%20subsets%20and%20the%20tumor%20microenvironment%20is%20essential%20for%20sustained%20cytotoxic%20activity&journal=Sci%20Immunol&doi=10.1126%2Fsciimmunol.abd4344&volume=6&publication_year=2021&author=Boulch%2CM&author=Cazaux%2CM&author=Loe-Mie%2CY&author=Thibaut%2CR&author=Corre%2CB&author=Lemaitre%2CF&author=Grandjean%2CCL&author=Garcia%2CZ&author=Bousso%2CP?
- What's the monthly income of https://doi.org/10.1038%2Fs41591-020-1061-7?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33020644
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446909?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Characteristics%20of%20anti-CD19%20CAR%20T%20cell%20infusion%20products%20associated%20with%20efficacy%20and%20toxicity%20in%20patients%20with%20large%20B%20cell%20lymphomas&journal=Nat%20Med&doi=10.1038%2Fs41591-020-1061-7&volume=26&pages=1878-1887&publication_year=2020&author=Deng%2CQ&author=Han%2CG&author=Puebla-Osorio%2CN&author=Ma%2CMCJ&author=Strati%2CP&author=Chasen%2CB&author=Dai%2CE&author=Dang%2CM&author=Jain%2CN&author=Yang%2CH each month?
- Revenue of https://doi.org/10.1158%2F2159-8290.CD-20-1677
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33820778 earn?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419030?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Integrative%20bulk%20and%20single-cell%20profiling%20of%20premanufacture%20T-cell%20populations%20reveals%20factors%20mediating%20long-term%20persistence%20of%20CAR%20T-cell%20therapy&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-20-1677&volume=11&pages=2186-2199&publication_year=2021&author=Chen%2CGM&author=Chen%2CC&author=Das%2CRK&author=Gao%2CP&author=Chen%2CCH&author=Bandyopadhyay%2CS&author=Ding%2CYY&author=Uzun%2CY&author=Yu%2CW&author=Zhu%2CQ?
- How much does https://doi.org/10.1158%2F2159-8290.CD-20-1661 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33837065 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561746 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=IFNgamma%20is%20critical%20for%20CAR%20T%20cell-mediated%20cyeloid%20activation%20and%20induction%20of%20endogenous%20immunity&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-20-1661&volume=11&pages=2248-2265&publication_year=2021&author=Alizadeh%2CD&author=Wong%2CRA&author=Gholamin%2CS&author=Maker%2CM&author=Aftabizadeh%2CM&author=Yang%2CX&author=Pecoraro%2CJR&author=Jeppson%2CJD&author=Wang%2CD&author=Aguilar%2CB rake in every month?
- https://doi.org/10.1038%2Fs41467-021-22872-z income
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34001881 income
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128874 make?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Longitudinal%20single-cell%20profiling%20reveals%20molecular%20heterogeneity%20and%20tumor-immune%20evolution%20in%20refractory%20mantle%20cell%20lymphoma&journal=Nat%20Commun&doi=10.1038%2Fs41467-021-22872-z&volume=12&publication_year=2021&author=Zhang%2CS&author=Jiang%2CVC&author=Han%2CG&author=Hao%2CD&author=Lian%2CJ&author=Liu%2CY&author=Zhang%2CR&author=McIntosh%2CJ&author=Wang%2CR&author=Dang%2CM
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=iTALK%3A%20an%20R%20package%20to%20characterize%20and%20illustrate%20intercellular%20communication&journal=BioRxiv&volume=1&publication_year=2019&author=Yuanxin%20Wang%2CRW&author=Zhang%2CS&author=Song%2CS&author=Jiang%2CC&author=Han%2CG&author=Wang%2CM&author=Ajani%2CJ&author=Futreal%2CA&author=Wang%2CL?
- What's the financial intake of https://doi.org/10.1038%2Fs41598-020-70584-z?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32826923 income
- Financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442638
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Cytokine%20profiling%20in%20serum-derived%20exosomes%20isolated%20by%20different%20methods&journal=Sci%20Rep&doi=10.1038%2Fs41598-020-70584-z&volume=10&publication_year=2020&author=Jung%2CHH&author=Kim%2CJY&author=Lim%2CJE&author=Im%2CYH?
- How much profit does https://doi.org/10.1136%2Fjitc-2021-002899 make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34353849 generate?
- See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344275 makes per month
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Deregulation%20of%20HLA-I%20in%20cancer%20and%20its%20central%20importance%20for%20immunotherapy&journal=J%20Immunother%20Cancer&doi=10.1136%2Fjitc-2021-002899&volume=9&publication_year=2021&author=Hazini%2CA&author=Fisher%2CK&author=Seymour%2CL
- https://doi.org/10.3892%2Fol.2017.6784's financial summary
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29085437 bring in?
- Monthly income for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649701
- How much does http://scholar.google.com/scholar_lookup?&title=HLA-mediated%20tumor%20escape%20mechanisms%20that%20may%20impair%20immunotherapy%20clinical%20outcomes%20via%20T-cell%20activation&journal=Oncol%20Lett&doi=10.3892%2Fol.2017.6784&volume=14&pages=4415-4427&publication_year=2017&author=Rodriguez%2CJA pull in monthly?
- How much revenue does https://doi.org/10.1038%2Fs41577-020-00490-y produce monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33526920 each month?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849958 generate?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20in%20the%20era%20of%20increasing%20myeloid%20cell%20diversity&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fs41577-020-00490-y&volume=21&pages=485-498&publication_year=2021&author=Veglia%2CF&author=Sanseviero%2CE&author=Gabrilovich%2CDI?
- How much revenue does https://doi.org/10.1126%2Fscitranslmed.aav5599 produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31217338 make?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724184 make?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Targetable%20genetic%20alterations%20of%20TCF4%20%28E2-2%29%20drive%20immunoglobulin%20expression%20in%20diffuse%20large%20B%20cell%20lymphoma&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.aav5599&volume=11&publication_year=2019&author=Jain%2CN&author=Hartert%2CK&author=Tadros%2CS&author=Fiskus%2CW&author=Havranek%2CO&author=Ma%2CMCJ&author=Bouska%2CA&author=Heavican%2CT&author=Kumar%2CD&author=Deng%2CQ?
- Get to know https://doi.org/10.1182%2Fblood.2019003880's earnings
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32315407?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Targeting%20cytokine-%20and%20therapy-induced%20PIM1%20activation%20in%20preclinical%20models%20of%20T-cell%20acute%20lymphoblastic%20leukemia%20and%20lymphoma&journal=Blood&doi=10.1182%2Fblood.2019003880&volume=135&pages=1685-1695&publication_year=2020&author=Smedt%2CR&author=Morscio%2CJ&author=Reunes%2CL&author=Roels%2CJ&author=Bardelli%2CV&author=Lintermans%2CB&author=Loocke%2CW&author=Almeida%2CA&author=Cheung%2CLC&author=Kotecha%2CRS?
- Check the income stats for https://doi.org/10.3389%2Ffimmu.2019.00481
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30930905 bring in?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423481 make?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20antibody%20checkpoints%20to%20enhance%20cancer%20immunotherapy-focus%20on%20fcgammaRIIB&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2019.00481&volume=10&publication_year=2019&author=Teige%2CI&author=Martensson%2CL&author=Frendeus%2CBL?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32060843
- See how much http://scholar.google.com/scholar_lookup?&title=CCL4%20signaling%20in%20the%20tumor%20microenvironment&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-3-030-36667-4_3&volume=1231&pages=23-32&publication_year=2020&author=Mukaida%2CN&author=Sasaki%2CSI&author=Baba%2CT makes per month
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32060845?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20multifaceted%20roles%20of%20CXCL9%20within%20the%20tumor%20microenvironment&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-3-030-36667-4_5&volume=1231&pages=45-51&publication_year=2020&author=Neo%2CSY&author=Lundqvist%2CA produce monthly?
- What's the financial gain of https://doi.org/10.1038%2Fs41467-019-10369-9?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31186412
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559950
- How much does http://scholar.google.com/scholar_lookup?&title=LIF%20regulates%20CXCL9%20in%20tumor-associated%20macrophages%20and%20prevents%20CD8%28%2B%29%20T%20cell%20tumor-infiltration%20impairing%20anti-PD1%20therapy&journal=Nat%20Commun&doi=10.1038%2Fs41467-019-10369-9&volume=10&publication_year=2019&author=Pascual-Garcia%2CM&author=Bonfill-Teixidor%2CE&author=Planas-Rigol%2CE&author=Rubio-Perez%2CC&author=Iurlaro%2CR&author=Arias%2CA&author=Cuartas%2CI&author=Sala-Hojman%2CA&author=Escudero%2CL&author=Martinez-Ricarte%2CF bring in each month?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34286442?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=CXCL13%20signaling%20in%20the%20tumor%20microenvironment&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-3-030-62658-7_6&volume=1302&pages=71-90&publication_year=2021&author=Hussain%2CM&author=Liu%2CJ&author=Wang%2CGZ&author=Zhou%2CGB have monthly?
- How much revenue does https://doi.org/10.1038%2Fs41598-019-46491-3 produce monthly?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31628349?
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802083 making per month?
- Profit of http://scholar.google.com/scholar_lookup?&title=Transcriptome%20network%20analysis%20identifies%20CXCL13-CXCR5%20signaling%20modules%20in%20the%20prostate%20tumor%20immune%20microenvironment&journal=Sci%20Rep&doi=10.1038%2Fs41598-019-46491-3&volume=9&publication_year=2019&author=Ohandjo%2CAQ&author=Liu%2CZ&author=Dammer%2CEB&author=Dill%2CCD&author=Griffen%2CTL&author=Carey%2CKM&author=Hinton%2CDE&author=Meller%2CR&author=Lillard%2CJW
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31783776
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884764?
- How much does http://scholar.google.com/scholar_lookup?&title=Soluble%20immune%20checkpoint-related%20proteins%20as%20predictors%20of%20tumor%20recurrence%2C%20survival%2C%20and%20T%20cell%20phenotypes%20in%20clear%20cell%20renal%20cell%20carcinoma%20patients&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-019-0810-y&volume=7&publication_year=2019&author=Wang%2CQ&author=Zhang%2CJ&author=Tu%2CH&author=Liang%2CD&author=Chang%2CDW&author=Ye%2CY&author=Wu%2CX pull in?
- How much cash flow does https://doi.org/10.2147%2FCMAR.S162478 have monthly?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29760564
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937498 pull in?
- http://scholar.google.com/scholar_lookup?&title=Highly%20elevated%20soluble%20Tim-3%20levels%20correlate%20with%20increased%20hepatocellular%20carcinoma%20risk%20and%20poor%20survival%20of%20hepatocellular%20carcinoma%20patients%20in%20chronic%20hepatitis%20B%20virus%20infection&journal=Cancer%20Manag%20Res&doi=10.2147%2FCMAR.S162478&volume=10&pages=941-951&publication_year=2018&author=Li%2CF&author=Li%2CN&author=Sang%2CJ&author=Fan%2CX&author=Deng%2CH&author=Zhang%2CX&author=Han%2CQ&author=Lv%2CY&author=Liu%2CZ's financial summary
- How much money does https://doi.org/10.3389%2Ffonc.2019.01015 generate?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31681568
- Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803523
- How much does http://scholar.google.com/scholar_lookup?&title=Soluble%20programmed%20death%20receptor%20ligands%20sPD-L1%20and%20sPD-L2%20as%20liquid%20biopsy%20markers%20for%20prognosis%20and%20platinum%20response%20in%20epithelial%20ovarian%20cancer&journal=Front%20Oncol&doi=10.3389%2Ffonc.2019.01015&volume=9&publication_year=2019&author=Buderath%2CP&author=Schwich%2CE&author=Jensen%2CC&author=Horn%2CPA&author=Kimmig%2CR&author=Kasimir-Bauer%2CS&author=Rebmann%2CV net monthly?
- Learn about the earnings of https://doi.org/10.1111%2Fbjh.17502
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34019713
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Screening%20and%20monitoring%20of%20the%20BTK%28C481S%29%20mutation%20in%20a%20real-world%20cohort%20of%20patients%20with%20relapsed%2Frefractory%20chronic%20lymphocytic%20leukaemia%20during%20ibrutinib%20therapy&journal=Br%20J%20Haematol&doi=10.1111%2Fbjh.17502&volume=194&pages=355-364&publication_year=2021&author=Bodor%2CC&author=Kotmayer%2CL&author=Laszlo%2CT&author=Takacs%2CF&author=Barna%2CG&author=Kiss%2CR&author=Sebestyen%2CE&author=Nagy%2CT&author=Hegyi%2CLL&author=Mikala%2CG is on a monthly basis
- How much profit does https://doi.org/10.1126%2Fscitranslmed.aau1167 make?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31068440
- How much does http://scholar.google.com/scholar_lookup?&title=Metabolic%20reprogramming%20toward%20oxidative%20phosphorylation%20identifies%20a%20therapeutic%20target%20for%20mantle%20cell%20lymphoma&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.aau1167&volume=11&publication_year=2019&author=Zhang%2CL&author=Yao%2CY&author=Zhang%2CS&author=Liu%2CY&author=Guo%2CH&author=Ahmed%2CM&author=Bell%2CT&author=Zhang%2CH&author=Han%2CG&author=Lorence%2CE net monthly?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29851933?
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469642 making per month?
- http://scholar.google.com/scholar_lookup?&title=The%20use%20of%20chimeric%20antigen%20receptor%20T%20cells%20in%20patients%20with%20non-Hodgkin%20lymphoma&journal=Clin%20Adv%20Hematol%20Oncol&volume=16&pages=375-386&publication_year=2018&author=Lulla%2CPD&author=Hill%2CLC&author=Ramos%2CCA&author=Heslop%2CHE's financial summary
- How much does https://doi.org/10.1158%2F2159-8290.CD-21-1586 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35554512 earn?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Sequential%20single-cell%20transcriptional%20and%20protein%20marker%20profiling%20reveals%20TIGIT%20as%20a%20marker%20of%20CD19%20CAR-T%20cell%20dysfunction%20in%20patients%20with%20non-Hodgkin%20lymphoma&journal=Cancer%20Discovery&doi=10.1158%2F2159-8290.CD-21-1586&volume=12&pages=1886-1903&publication_year=2022&author=Jackson%2CZ&author=Hong%2CCJ&author=Schauner%2CR&author=Dropulic%2CB&author=Caimi%2CPF&author=Lima%2CM&author=Giraudo%2CMF&author=Gupta%2CK&author=Reese%2CJS&author=Hwang%2CTH&author=Wald%2CDN?
- How much revenue does https://doi.org/10.3389%2Ffimmu.2018.02821 bring in?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30555485
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281988
- How much does http://scholar.google.com/scholar_lookup?&title=Intrinsic%20expression%20of%20immune%20checkpoint%20molecule%20TIGIT%20could%20help%20tumor%20growth%20in%20vivo%20by%20suppressing%20the%20function%20of%20NK%20and%20CD8%28%2B%29%20t%20cells&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2018.02821&volume=9&publication_year=2018&author=Zhou%2CXM&author=Li%2CWQ&author=Wu%2CYH&author=Han%2CL&author=Cao%2CXG&author=Yang%2CXM&author=Wang%2CHF&author=Zhao%2CWS&author=Zhai%2CWJ&author=Qi%2CYM&author=Gao%2CYF pull in?
- Get to know https://doi.org/10.3389%2Ffonc.2020.00188's earnings
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32161718?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052362 make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20macrophages%3A%20recent%20insights%20and%20therapies&journal=Front%20Oncol&doi=10.3389%2Ffonc.2020.00188&volume=10&publication_year=2020&author=Zhou%2CJ&author=Tang%2CZ&author=Gao%2CS&author=Li%2CC&author=Feng%2CY&author=Zhou%2CX bring in?
- Earnings of https://doi.org/10.3390%2Fjcm10132872
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34203451 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268873 make?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=MDSC%20in%20mice%20and%20men%3A%20mechanisms%20of%20immunosuppression%20in%20cancer&journal=J%20Clin%20Med&doi=10.3390%2Fjcm10132872&volume=10&publication_year=2021&author=Vanhaver%2CC&author=Bruggen%2CP&author=Bruger%2CAM
- What are the total earnings of https://doi.org/10.1016%2Fj.cellimm.2021.104302?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33592540 is on a monthly basis
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054443 generate?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20%28MDSC%29%3A%20when%20good%20intentions%20go%20awry&journal=Cell%20Immunol&doi=10.1016%2Fj.cellimm.2021.104302&volume=362&publication_year=2021&author=Sanchez-Pino%2CMD&author=Dean%2CMJ&author=Ochoa%2CAC?
- Explore the financials of https://doi.org/10.1016%2Fj.immuni.2021.04.004
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33979585?
- Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709560
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=MDSC%3A%20markers%2C%20development%2C%20states%2C%20and%20unaddressed%20complexity&journal=Immunity&doi=10.1016%2Fj.immuni.2021.04.004&volume=54&pages=875-884&publication_year=2021&author=Hegde%2CS&author=Leader%2CAM&author=Merad%2CM is on a monthly basis
- What's the monthly money flow for https://doi.org/10.1038%2Fsrep29521?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27405665 earning monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942787 make?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20targeting%20of%20myeloid-derived%20suppressor%20cells%20involves%20a%20novel%20mechanism%20mediated%20by%20clusterin&journal=Sci%20Rep&doi=10.1038%2Fsrep29521&volume=6&publication_year=2016&author=Zhou%2CJM&author=Donatelli%2CSS&author=Gilvary%2CDL&author=Tejera%2CMM&author=Eksioglu%2CEA&author=Chen%2CXH&author=Coppola%2CD&author=Wei%2CS&author=Djeu%2CJY
- How much does https://doi.org/10.1158%2F0008-5472.CAN-11-2905 bring in each month?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22282653 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543151
- See how much http://scholar.google.com/scholar_lookup?&title=Myeloid%20progenitor%20cells%20in%20the%20Premetastatic%20lung%20promote%20metastases%20by%20inducing%20mesenchymal%20to%20epithelial%20transition&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-11-2905&volume=72&pages=1384-1394&publication_year=2012&author=Gao%2CDC&author=Joshi%2CN&author=Choi%2CHJ&author=Ryu%2CSH&author=Hahn%2CM&author=Catena%2CR&author=Sadik%2CH&author=Argani%2CP&author=Wagner%2CP&author=Vahdat%2CLT makes per month
- What's the income generated by https://doi.org/10.3390%2Fcells9081785 each month?
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464644
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Role%20of%20tumor-associated%20myeloid%20cells%20in%20breast%20cancer&journal=Cells&doi=10.3390%2Fcells9081785&volume=9&publication_year=2020&author=Cha%2CYJ&author=Koo%2CJS generate?
- https://doi.org/10.1080%2F2162402X.2018.1469594's total income per month
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30228937 generate?
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140587's earnings
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=VISTA%20is%20highly%20expressed%20on%20MDSCs%20and%20mediates%20an%20inhibition%20of%20T%20cell%20response%20in%20patients%20with%20AML&journal=Oncoimmunology&doi=10.1080%2F2162402X.2018.1469594&volume=7&publication_year=2018&author=Wang%2CL&author=Jia%2CB&author=Claxton%2CDF&author=Ehmann%2CWC&author=Rybka%2CWB&author=Mineishi%2CS&author=Naik%2CS&author=Khawaja%2CMR&author=Sivik%2CJ&author=Han%2CJ is on a monthly basis
- How much profit does https://doi.org/10.1158%2F2326-6066.CIR-20-0433 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33579728
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137571's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20PIM1-mediated%20metabolism%20in%20myeloid%20suppressor%20cells%20to%20treat%20cancer&journal=Cancer%20Immunology%20Research&doi=10.1158%2F2326-6066.CIR-20-0433&volume=9&pages=454-469&publication_year=2021&author=Xin%2CG&author=Chen%2CY&author=Topchyan%2CP&author=Kasmani%2CMY&author=Burns%2CR&author=Volberding%2CPJ&author=Wu%2CXP&author=Cohn%2CA&author=Chen%2CYL&author=Lin%2CCW make?
- How much cash flow does https://doi.org/10.1158%2F0008-5472.CAN-16-0839 have monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27503932 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050142
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Adaptive%20NK%20cells%20with%20low%20TIGIT%20expression%20are%20inherently%20resistant%20to%20myeloid-derived%20suppressor%20cells&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-16-0839&volume=76&pages=5696-5706&publication_year=2016&author=Sarhan%2CD&author=Cichocki%2CF&author=Zhang%2CB&author=Yingst%2CA&author=Spellman%2CSR&author=Cooley%2CS&author=Verneris%2CMR&author=Blazar%2CBR&author=Miller%2CJS?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1186/s12943-022-01655-0?format=refman&flavour=references generate?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vivian%20Changying%20Jiang
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vivian%20Changying%20Jiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dapeng%20Hao
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dapeng%20Hao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Preetesh%20Jain making per month?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Preetesh%20Jain%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yijing%20Li generate monthly?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yijing%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qingsong%20Cai earning monthly?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qingsong%20Cai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yixin%20Yao
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yixin%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lei%20Nie make?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lei%20Nie%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yang%20Liu?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yang%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jingling%20Jin
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jingling%20Jin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wei%20Wang?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Heng-Huan%20Lee
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Heng-Huan%20Lee%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuxuan%20Che income
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuxuan%20Che%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Enyu%20Dai?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Enyu%20Dai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guangchun%20Han generate monthly?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guangchun%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ruiping%20Wang generate?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ruiping%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kunal%20Rai's revenue stream
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kunal%20Rai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andrew%20Futreal?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andrew%20Futreal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christopher%20Flowers bring in?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christopher%20Flowers%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Linghua%20Wang makes per month
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Linghua%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20Wang
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much does https://static-content.springer.com/esm/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_MOESM1_ESM.docx rake in every month?
- Earnings of http://creativecommons.org/licenses/by/4.0/
- How much revenue does http://creativecommons.org/publicdomain/zero/1.0/ produce monthly?
- How much does https://s100.copyright.com/AppDispatchServlet?title=TIGIT%20is%20the%20central%20player%20in%20T-cell%20suppression%20associated%20with%20CAR%20T-cell%20relapse%20in%20mantle%20cell%20lymphoma&author=Vivian%20Changying%20Jiang%20et%20al&contentID=10.1186%2Fs12943-022-01655-0©right=The%20Author%28s%29&publication=1476-4598&publicationDate=2022-09-26&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 rake in every month?
- https://crossmark.crossref.org/dialog/?doi=10.1186/s12943-022-01655-0's revenue stream
- What's the financial gain of https://citation-needed.springer.com/v2/references/10.1186/s12943-022-01655-0?format=refman&flavour=citation?
- How much money does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral make?
- How much revenue does https://www.springernature.com/gp/products produce monthly?
- https://www.springernature.com/gp/librarians's financial summary
- Monthly income for https://www.springernature.com/gp/societies
- What's the monthly income of https://www.springernature.com/gp/partners?
- How much revenue does https://www.springer.com/ produce monthly?
- Financial intake of https://www.nature.com/
- How much revenue does https://www.biomedcentral.com/ bring in?
- How much revenue does https://www.palgrave.com/ produce monthly?
- How profitable is https://www.apress.com/?
- What are the total earnings of https://www.springernature.com/gp/legal/ccpa?
- How much cash flow does https://www.springernature.com/gp/info/accessibility have monthly?
- What's the financial intake of https://support.springernature.com/en/support/home?
- What's the financial outcome of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- Discover the revenue of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref